CELC — Celcuity Inc.

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1603454 ·
Last close
$58.01
Market Cap
$2.84B
52W High
$151.02
52W Low
$53.54
ADV30
1,542,085
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -77,319,000 -73,337,000 726,869,000 178,165,000 800,908,000
Jun 2026 0 — -66,118,000 -78,864,000 828,220,000 182,049,000 841,001,000
Mar 2026 0 — -50,507,000 -52,841,000 410,164,000 145,191,000 356,639,000
Dec 2025 0 — -49,201,000 -50,973,000 466,558,000 165,703,000 366,003,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-191,706,000
Investing CF
$-450,273,000
Financing CF
$777,674,000
CapEx
$-571,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.30
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-580,602,000
Inventory
—
Receivables
—
ST Investments
$571,995,000
EBIT TTM
$-204,213,000
Pretax Income TTM
$-226,482,000
Interest Exp TTM
$22,269,000
Analysts
13

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -172,192,000 -177,042,000 466,558,000 366,003,000 100,555,000 -153,280,000
Dec 2024 0 -113,267,000 -111,779,000 245,123,000 129,504,000 115,619,000 -83,467,000
Dec 2023 0 -66,230,331 -63,779,116 191,219,398 51,450,076 139,769,322 -53,812,253
Dec 2022 0 -39,391,091 -40,370,040 175,697,097 41,925,630 133,771,467 -36,008,171

TTM Snapshot

Revenues TTM
$15,939,000
NetIncome TTM
$-226,482,000
OpCashFlow TTM
—
Assets (Latest)
$828,220,000
Forward EPS
$0.57

Max Pain — expiry 2027-01-15

max pain strike: $60.00 · spot: $55.60 · call oi: 7,343 · put oi: 2,225
Expected Move to 2027-01-15: ±$13.45 (24.19%) — implied range $42.15 – $69.05 · ATM straddle on $55.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
PGNY Progyny, Inc. $2.70B $36.71 —
AVAH Aveanna Healthcare Holdings, Inc. $2.54B $11.65 —
PRVA Privia Health Group, Inc. $3.19B $24.99 —
ARDT Ardent Health, Inc. $2.50B $17.75 —
NHC NATIONAL HEALTHCARE CORP $3.22B $205.77 —

News headlines (Yahoo Finance, 1h cache)

Celcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer
2026-11-09 13:30 · Yahoo
Celcuity (CELC) Q3 2026 Earnings Call Transcript
2026-11-06 17:05 · Yahoo
Celcuity Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Celcuity Inc (CELC) Q3 2026 Earnings Call Highlights: Revtorpic's Strong Launch Momentum Meets ...
2026-11-06 07:22 · Yahoo
What Celcuity (CELC) Said on Its Q3 Earnings Call
2026-11-06 03:14 · Yahoo
Celcuity Inc. Reports Third Quarter 2026 Financial Results and Provides Corporate Update
2026-11-05 21:01 · Yahoo
Celcuity Schedules Release of Third Quarter 2026 Financial Results and Webcast/Conference Call
2026-10-29 12:30 · Yahoo
Will Breast And Prostate Cancer Data Change Celcuity (CELC) Narrative
2026-10-25 20:10 · Yahoo
Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026
2026-10-24 08:15 · Yahoo
Celcuity Presents Updated Data from a Phase 1b/2 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration-Resistant Prostate Cancer at the ESMO Congress 2026
2026-10-23 13:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.